Navigation Links
Space research institute awards postdoctoral fellowships to 4 scientists
Date:11/9/2012

HOUSTON (Nov. 8, 2012) Four young scientists have received postdoctoral fellowships from the National Space Biomedical Research Institute (NSBRI). Through this two-year program, they conduct research with the eventual aim of protecting astronaut health during long-duration spaceflights.

In addition to receiving mentorship from a faculty member at their home institution, the fellows are members of one of NSBRI's seven research teams. This allows them to interact with some of the nation's leading researchers in their fields and to participate in NSBRI and NASA meetings.

"This class is filled with some of the most promising young researchers this nation has to offer," said Dr. Jeffrey P. Sutton, NSBRI president and CEO. "The fellows benefit from the program through the research experience they gain and the interactions they have with leading scientists. The human spaceflight community is also a beneficiary because NSBRI Postdoctoral Fellows have a history of conducting research that is valuable in reducing the health risks associated with long-duration spaceflight, and in improving life on Earth."

The 2012-2014 NSBRI fellows, their institutions, teams and mentors are:

Brandon Macias
University of California, San Diego
NSBRI Team: Cardiovascular Alterations Team
Mentor: Alan Hargens, Ph.D.

Frances Meredith, Ph.D.
University of Colorado Denver
NSBRI Team: Sensorimotor Adaptation Team
Mentor: Katherine Rennie, Ph.D.

Anthony Lau, Ph.D.
University of North Carolina at Chapel Hill
NSBRI Team: Musculoskeletal Alterations Team
Mentor: Ted Bateman, Ph.D.

Michael Lee, Ph.D.
Brigham and Women's Hospital - Harvard Medical School
NSBRI Team: Human Factors and Performance Team
Mentor: Elizabeth Klerman, M.D., Ph.D.

Each participant receives a $42,500 stipend per year and additional funds to cover health insurance and travel to NSBRI-related meetings. The fellows also have an opportunity to attend the Summer Bioastronautics Institute (SBI) at NSBRI's headquarters and demonstration laboratories in the BioScience Research Collaborative in Houston. The SBI emphasizes essential skills needed for a successful research career and connects the trainees with the NSBRI and NASA scientific communities. The SBI includes participants from NSBRI's Summer Internship Program and Graduate Education Program in Space Life Sciences.

The NSBRI Postdoctoral Fellowship Program solicits applications annually. Applicants submit research project proposals to investigate a spaceflight-related health risk or to develop a technology needed to enable research or medical care in space. The project must be overseen by an experienced mentor and be carried out at a U.S. laboratory. Applications are reviewed for scientific and technical merit by an independent review panel and by NSBRI management to ensure relevance to the Institute's research program goals. Also, a competitive third-year extension of the fellowship is available. Information about NSBRI's Postdoctoral Fellowship Program and this year's class is available at www.nsbri.org/postdocs.

Since its inception in 2004, the NSBRI Postdoctoral Fellowship Program has had 32 participants.


'/>"/>

Contact: Brad Thomas
rbthomas@bcm.edu
713-798-7595
National Space Biomedical Research Institute
Source:Eurekalert

Related biology news :

1. Space research institute awards postdoctoral fellowships to four scientists
2. Sharing space:
3. Why astronauts experience low blood pressure after returning to Earth from space
4. University of Tennessee Space Institute researchers make clinical trials a virtual reality
5. UA engineering professor uses aerospace materials to build endless pipeline
6. NSBRI renews space life sciences graduate programs at MIT, Texas A&M
7. Space research institute awards funding to promising medical products
8. University of Tennessee Space Institute researchers develop laser technology to fight cancer
9. What does a tree growing faster than its neighbor look like from outer space?
10. Scientists make stunning inner space observations
11. Researchers announce GenomeSpace environment to connect genomic tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: